Home › Enlarged Prostate (BPH) › NCT07538622
Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry
Who can join
Ages 18 and older · Men
Full eligibility criteria
Inclusion Criteria: * Treatment with Zenflow Spring System will be conducted in accordance with the approved Instructions for Use Exclusion Criteria: * Treatment with Zenflow Spring System will be conducted in accordance with the approved Instructions for Use
About the study
The purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spring System performs during the implant procedure, and at follow-up visits at 1, 3, 6, and 12 months. We will look at how symptoms improve, how quickly patients return to normal activities, how satisfied they are with treatment, and whether there are any problems or side effects related to the device.
What is being tested
- Zenflow Spring System (device)
Sponsor: Zenflow, Inc. · Participants: 300 · Started: Jul 29, 2026
Contact the study team
Official record on ClinicalTrials.gov — NCT07538622
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.